ArticleDiabetes, obesity & metabolism2024

Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery.

Jason M Samuels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.